AI assistant
Sending…
RESMED INC — Director's Dealing 2015
Mar 20, 2015
30071_dirs_2015-03-20_9926d9d1-b0c2-4719-8482-01b04f74ea90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-03-18
Reporting Person: Reiser Anne (President - ResMed Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-18 | ResMed Common Stock | M | 4000 | $17.30 | Acquired | 72120.212 | Direct |
| 2015-03-18 | ResMed Common Stock | S | 4000 | $71.45 | Disposed | 68120.212 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-18 | ResMed NQ Stock Options | $17.30 | M | 4000 | Disposed | 2015-11-24 | ResMed Common Stock (4000) | Direct |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29